相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Risk profiling for a refractory course of rheumatoid arthritis
Manuel Becede et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2019)
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
Peter C. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
Roy Fleischmann et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Biologic efficacy optimization-a step towards personalized medicine
Patrick D. W. Kiely
RHEUMATOLOGY (2016)
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2016)
Baricitinib in Patients with Refractory Rheumatoid Arthritis
Mark C. Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent: Trajectories of Disease Activity in a Large Multinational Cohort Study
D. S. Courvoisier et al.
EBIOMEDICINE (2016)
Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010
Anna-Birgitte Aga et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
Edward C. Keystone et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Distinct Trajectories of Disease Activity Over the First Year in Early Rheumatoid Arthritis Patients Following a Treat-to-Target Strategy
Liseth Siemons et al.
ARTHRITIS CARE & RESEARCH (2014)
Growth mixture models in longitudinal research
Jost Reinecke et al.
ASTA-ADVANCES IN STATISTICAL ANALYSIS (2011)
Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change
K Bruynesteyn et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
D Aletaha et al.
ARTHRITIS RESEARCH & THERAPY (2005)
分享论文
